← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1993Last known activity
Nov 12, 2025
Timeline
1900s
- Jun 30, 1906
Food and Drug Administration— Founded
Drugs by trial phase (166 distinct, 155 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (53 own, 0 via acquisition)
Other trials (23 own, 0 via acquisition)
Indications
Studied for
- Acute Chest Syndrome
- Acute Lung Injury
- Adrenoleukodystrophy
- Amyloid Neuropathies
- Amyloid Neuropathies, Familial
- Amyloidosis
- Amyloidosis, Familial
- Anemia
- Anemia, Aplastic
- Anemia, Hemolytic
- Anemia, Hemolytic, Congenital
- Anemia, Sickle Cell
- Arachnodactyly
- Autistic Disorder
- Bacterial Infections
- Body Dysmorphic Disorders
- Brain Injuries
- Brain Injuries, Traumatic
- Bronchiolitis
- Bronchiolitis Obliterans
- Bronchopulmonary Dysplasia
- Candidiasis
- Carcinoma
- Carcinoma, Hepatocellular
- Cardiotoxicity
- Cerebral Hemorrhage
- Chagas Disease
- Coccidioidomycosis
- Coccidiosis
- Congenital Abnormalities
- Crohn Disease
- Cystic Fibrosis
- Deficiency Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Digestive System Diseases
- Disease
- Epilepsy
- Fanconi Anemia
- Fanconi Syndrome
- Fatty Liver
- Fibrosis
- Gastroesophageal Reflux
- Gastrointestinal Diseases
- Graft vs Host Disease
- Granulomatosis with Polyangiitis
- Guillain-Barre Syndrome
- Head and Neck Neoplasms
- Heart Defects, Congenital
- Hemangioendothelioma
- Hemangioma
- Hematologic Diseases
- Hemorrhage
- Hemorrhagic Fever, Ebola
- Hepatic Veno-Occlusive Disease
- Huntington Disease
- Hypercapnia
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Hyperphagia
- Immunoglobulin Light-chain Amyloidosis
- Immunologic Deficiency Syndromes
- Infant, Newborn, Diseases
- Infections
- Influenza, Human
- Kasabach-Merritt Syndrome
- Kidney Diseases
- Lead Poisoning
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lipodystrophy
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Long QT Syndrome
- Lung Diseases
- Lymphangioleiomyomatosis
- Lymphoma
- Lysosomal Storage Diseases
- Marfan Syndrome
- Marijuana Abuse
- Melanoma
- Mitochondrial Diseases
- Mood Disorders
- Mucopolysaccharidoses
- Mucopolysaccharidosis I
- Muscle Weakness
- Myasthenia Gravis
- Mycobacterium avium-intracellulare Infection
- Mycobacterium Infections
- Mycoses
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Nephrosis
- Nephrotic Syndrome
- Neurofibroma
- Neurofibroma, Plexiform
- Neurofibromatoses
- Neurofibromatosis 1
- Nutrition Disorders
Recent trials (50)
- NCT07287137CollaboratorPhase 4Nov 12, 2025
- NCT07176208Lead sponsorPhase 1Sep 22, 2025
- NCT07001254CollaboratorPhase 2Jul 31, 2025
- NCT07223450CollaboratorPhase 1Jun 12, 2025
- NCT06953726CollaboratorPhase 4Jun 2, 2025
- NCT06529731CollaboratorPhase 2Aug 22, 2024
- NCT06239480CollaboratorPhase 3Jul 31, 2024
- NCT06306391CollaboratorPhase 1Mar 5, 2024
- NCT06192589Lead sponsorPhase 1Feb 8, 2024
- NCT06148311CollaboratorPhase 2Feb 1, 2024
- NCT05999383CollaboratorPhase 2Oct 31, 2023
- NCT06074016CollaboratorPhase 1Jul 12, 2023
- NCT05898217CollaboratorN/AJun 1, 2023
- NCT05470465Lead sponsorPhase 1Sep 1, 2022
- NCT05338632CollaboratorPhase 1Aug 16, 2022
Details
- Founded
- Silver Spring, MD, US Jun 30, 1906
- Last known activity
- Nov 12, 2025